{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:08:18Z","timestamp":1779404898360,"version":"3.53.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Arterial hypertension and endurance training are related to left atrial (LA) remodeling and risk of atrial fibrillation (AF). Serum blood biomarkers have been explored in relation to cardiovascular risk. Our aim was to assess the influence of patient and echocardiographic characteristics on serum blood biomarkers in individuals at risk for AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A population of 511 subjects was analyzed: 286 endurance athletes and 225 patients with arterial hypertension. Participants underwent 2D and 3D echocardiography with speckle-tracking analysis. Blood samples were obtained to evaluate biomarkers of myocardial damage (Brain Natriuretic Peptide, troponin I, Oncostatin M, heart-type Fatty Acid-Binding Protein and Placenta Growth Factor), vascular endothelial dysfunction (Endothelial cell-specific molecule 1), and fibrosis (Matrix Metalloproteinase 1, 2 and 9, C-X-C motif chemokine ligand 6 and 16, and Galectin-3 (Gal-3)). Linear regression models were fitted to discern the relationship of patient and echo characteristics and serum biomarker levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results revealed the significant influence of age, gender, body mass index and renal function on biomarker levels. Parameters of myocardial damage showed a limited range of values in our cohort with no differences between groups. Biomarkers of fibrosis were uniformly elevated in hypertension, with Gal-3 levels independently associated with LA reservoir strain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum levels of fibrosis biomarkers differ between populations at risk for AF. In hypertension Gal-3 levels are associated with LA reservoir function, making it a potential biomarker for LA remodeling in this setting. Clinical follow-up is needed to relate these findings with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmmed.2026.1801523","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:10:15Z","timestamp":1779401415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood biomarkers and atrial remodeling in patients at risk of atrial fibrillation"],"prefix":"10.3389","volume":"6","author":[{"given":"Filip","family":"Loncaric","sequence":"first","affiliation":[{"name":"Klinicki bolnicki centar Zagreb","place":["Zagreb, Croatia"]},{"name":"August Pi i Sunyer Biomedical Research Institute (IDIBAPS)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Forado Benatar","sequence":"additional","affiliation":[{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mimbrero Guillamon","sequence":"additional","affiliation":[{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Nunno","sequence":"additional","affiliation":[{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Jimenez-Arjona","sequence":"additional","affiliation":[{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Tirapu","sequence":"additional","affiliation":[{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Montserrat","sequence":"additional","affiliation":[{"name":"August Pi i Sunyer Biomedical Research Institute (IDIBAPS)","place":["Barcelona, Spain"]},{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sanchis","sequence":"additional","affiliation":[{"name":"August Pi i Sunyer Biomedical Research Institute (IDIBAPS)","place":["Barcelona, Spain"]},{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Doltra","sequence":"additional","affiliation":[{"name":"August Pi i Sunyer Biomedical Research Institute (IDIBAPS)","place":["Barcelona, Spain"]},{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Bijnens","sequence":"additional","affiliation":[{"name":"Institucio Catalana de Recerca i Estudis Avancats","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sitges","sequence":"additional","affiliation":[{"name":"August Pi i Sunyer Biomedical Research Institute (IDIBAPS)","place":["Barcelona, Spain"]},{"name":"Hospital Clinic de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/jch.12440","article-title":"Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?","volume":"16","author":"Afsar","year":"2014","journal-title":"J. Clin. Hypertens."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"Compendium of Physical activities: a second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med. Sci. Sports Exerc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/s0735-1097(03)00578-3","article-title":"Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat","volume":"42","author":"Boixel","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/01.HYP.0000257123.95372.ab","article-title":"Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts","volume":"49","author":"Choisy","year":"2007","journal-title":"Hypertension"},{"key":"B6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/0003319715625827","article-title":"Human endothelial cell-specific Molecule-1 (Endocan) and coronary artery disease and Microvascular angina","volume":"67","author":"\u00c7imen","year":"2016","journal-title":"Angiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/cvr\/cvq357","article-title":"Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation","volume":"89","author":"De Jong","year":"2011","journal-title":"Cardiovasc Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2217\/bmm-2018-0492","article-title":"Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review","volume":"13","author":"Draker","year":"2019","journal-title":"Biomark. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ahj.2017.07.001","article-title":"Galectin-3 and incidence of atrial fibrillation: the Atherosclerosis Risk in communities (ARIC) study","volume":"192","author":"Fashanu","year":"2017","journal-title":"Am. Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jacc.2020.07.055","article-title":"Cardiovascular biomarkers and imaging in older adults: JACC council perspectives","volume":"76","author":"Forman","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"EP Eur."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e23104","DOI":"10.1002\/jcla.23104","article-title":"Galectin-3 and risk of atrial fibrillation: a systematic review and meta-analysis","volume":"34","author":"Gong","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"Ho","year":"2014","journal-title":"Am. Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e59052","DOI":"10.1371\/journal.pone.0059052","article-title":"Novel association between plasma matrix Metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the atherosclerosis risk in communities study. Kronenberg F","volume":"8","author":"Huxley","year":"2013","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.3390\/ijms21165689","article-title":"Galectin-3, N-terminal propeptides of type I and III procollagen in patients with atrial fibrillation and metabolic syndrome","volume":"21","author":"Ionin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/eurheartj\/eht194","article-title":"Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy","volume":"34","author":"Kottkamp","year":"2013","journal-title":"Eur. Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.stem.2011.08.013","article-title":"Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling","volume":"9","author":"Kubin","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the european Association of cardiovascular imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. \u2013 Cardiovasc. Imaging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/bjsm.2006.031534","article-title":"Biochemical evidence of myocardial fibrosis in veteran endurance athletes","volume":"41","author":"Lindsay","year":"2007","journal-title":"Br. J. Sports Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"H815","DOI":"10.1152\/ajpheart.00948.2015","article-title":"CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis","volume":"311","author":"Ma","year":"2016","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ahj.2020.05.015","article-title":"High-intensity endurance training is associated with left atrial fibrosis","volume":"226","author":"Peritz","year":"2020","journal-title":"Am. Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.ijcard.2014.07.150","article-title":"Heart-type fatty acid-binding protein is a novel prognostic marker in patients with essential hypertension","volume":"176","author":"Setsuta","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.12659\/MSM.890635","article-title":"Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation","volume":"20","author":"Sonmez","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"B26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.amjhyper.2004.05.019","article-title":"Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the anglo-scandinavian cardiac Outcomes trial (ASCOT)","volume":"17","author":"Tayebjee","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/ehjci\/jeaa183","article-title":"Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function","volume":"21","author":"Trivedi","year":"2020","journal-title":"Eur. Heart J. Cardiovasc Imaging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/s0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CRD.0000000000000059","article-title":"Circulating biomarkers predictive of postoperative atrial fibrillation","volume":"24","author":"Turagam","year":"2016","journal-title":"Cardiol. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.113.01837","article-title":"Critical role of CXCL16 in hypertensive kidney injury and fibrosis","volume":"62","author":"Xia","year":"2013","journal-title":"Hypertension"},{"key":"B31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/jce.12637","article-title":"The association of serum Galectin-3 levels with atrial electrical and structural remodeling","volume":"26","author":"Yalcin","year":"2015","journal-title":"J. Cardiovasc Electrophysiol."}],"container-title":["Frontiers in Molecular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2026.1801523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:10:16Z","timestamp":1779401416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2026.1801523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":31,"alternative-id":["10.3389\/fmmed.2026.1801523"],"URL":"https:\/\/doi.org\/10.3389\/fmmed.2026.1801523","relation":{},"ISSN":["2674-0095"],"issn-type":[{"value":"2674-0095","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1801523"}}